Harnessing the potential of NHS commitments to skin cancer tech
March 27, 2024
.svg)
June 11, 2026
No clinician sets out to over-refer.
A GP escalating a patient to secondary care. An optometrist directing someone to A&E. A community clinician sending a case “just in case.” These are not examples of poor decision-making. They are examples of rational behaviour under pressure.
Healthcare is, by definition, a risk-heavy environment. Clinicians operate within overlapping layers of responsibility: professional accountability, regulatory scrutiny, patient expectation, and the ever-present possibility of adverse outcomes. In the NHS, that pressure is amplified by system constraints, limited time, incomplete information, and increasing demand.
When there is uncertainty about what happens next, escalation feels like the safest option. And in many cases, it is.
The problem is not that clinicians are making the wrong decisions. The problem is that the system often makes the right decision harder to see.
Clinical decision-making relies on clarity, clear thresholds, clear pathways, and clear feedback on outcomes. When those signals weaken, risk perception increases.
Across many NHS referral pathways, that clarity is inconsistent.
Urgency thresholds are not always applied in the same way across organisations. Documentation standards vary. Access to specialist advice can be limited or delayed. And perhaps most importantly, clinicians often lack visibility of what happens after a referral is made. This matters more than it might seem.
Research and policy guidance from NHS England has repeatedly highlighted unwarranted variation in referral patterns across the NHS, with similar patient cohorts experiencing very different pathways depending on geography and local practice. That variation is not simply a matter of clinical preference, it is often a reflection of differing levels of access to advice, diagnostics, and pathway clarity.
When those variables are unstable, the perception of risk rises. And when risk rises, escalation follows.
A GP faced with an ambiguous dermatology presentation may refer rather than wait for delayed advice. An optometrist uncertain about retinal findings may direct a patient to A&E rather than risk missing a serious condition. In each case, the decision is defensible. But at scale, these individual decisions accumulate into system-wide pressure.
Secondary care does not become saturated because clinicians are careless. It becomes saturated because they are appropriately cautious in an environment that lacks consistent visibility.
One of the defining characteristics of the NHS is that it absorbs risk.
When uncertainty exists in primary or community care, it is often transferred downstream. Referrals increase. A&E attendances rise. Specialist clinics become the point at which uncertainty is resolved. Over time, this creates a subtle but powerful shift in how services operate.
Clinics spend more time triaging volume rather than managing complexity. A&E departments see a growing proportion of cases that could potentially have been managed elsewhere, given the right support. Workforce pressure intensifies, not just because of demand, but because of the type of demand being managed.
Data from organisations such as NHS Providers consistently highlights the strain this places on frontline services, with rising attendances, workforce shortages, and increasing burnout forming a persistent backdrop to NHS delivery. This is the downstream effect of clinical uncertainty.
It is not always visible in financial reports, but it is felt operationally, through longer waiting times, reduced capacity for complex cases, and increasing pressure on staff.
It is tempting to frame over-referral as a behavioural issue. To suggest that clinicians are being overly cautious, or that thresholds are not being applied correctly. That framing is too simplistic, and, ultimately, unhelpful.
What is often described as “defensive referral” is better understood as a system behaviour. It emerges when clinicians are required to make decisions without sufficient clarity, support, or feedback.
In other words, it is not driven by individual risk aversion, but by structural uncertainty.
Consider a GP deciding whether to refer a patient with non-specific but potentially serious symptoms. Without rapid access to specialist input, clear referral criteria, or confidence in alternative pathways, the safest course of action is to refer. Not because it is clinically ideal, but because it reduces immediate risk.
This dynamic is reinforced by the broader context in which clinicians operate. Regulatory frameworks, public scrutiny, and the cultural legacy of high-profile clinical failures all contribute to an environment where missing a diagnosis carries significant consequences.
In that context, escalation is not just understandable. It is rational.
When clinical uncertainty drives escalation, the impact is often framed in financial terms, more referrals, more appointments, more cost. But the true cost is broader, and more insidious.
Operationally, increased referral volumes slow the system down. Time-critical cases must compete with precautionary ones. Waiting lists grow, not just because of demand, but because of how that demand is structured.
For the workforce, the impact is cumulative. Clinicians spend more time managing volume and less time applying their expertise to complex cases. Administrative burden increases. Fatigue builds.
For patients, the consequences are equally real. Longer waits. More fragmented care. Increased anxiety as they move through pathways that may not have been necessary in the first place.
These are not isolated issues. They are interconnected effects of a system that is absorbing uncertainty rather than resolving it early.
Admin teams that use Cinapsis estimated a 60% reduction in the time spent managing referrals. Read the full story.
If uncertainty drives escalation, the inverse is also true: clarity reduces it.
Where clinicians have access to timely specialist advice, clear referral criteria, and visibility of outcomes, decision-making changes. Not because clinicians become less cautious, but because they become more confident in alternative pathways.
This is where structured Advice & Refer models begin to have a measurable impact.
By enabling rapid, documented communication between primary and secondary care, A&G reduces the need for precautionary referral. It allows clinicians to validate decisions, access specialist input, and manage cases in the most appropriate setting.
NHS England has positioned Advice & Refer as a key component of elective recovery for this reason. When implemented effectively, it does not simply reduce referral volumes, it changes how decisions are made.
The effect is cumulative. Fewer unnecessary referrals mean more capacity for complex cases. Faster decision-making improves patient flow. Reduced administrative burden frees up clinical time.
In other words, improving clarity upstream restores capacity downstream.
The question, then, is not how to stop clinicians from referring. That approach misunderstands the problem.
The real question is how to make the right decision feel safer than escalation. That requires a shift in how systems are designed.
It means ensuring that when a clinician is uncertain, the easiest action is not to refer, but to seek structured advice. It means embedding visibility into pathways, so that clinicians understand not just what to do, but what happens next. And it means creating feedback loops, so that decisions are informed by outcomes rather than guesswork.
This is not about removing clinical judgement. It is about supporting it and improving clinical education so a similar presentation can be managed with greater confidence in the future.
Because when clinicians have the information, support, and confidence they need, escalation becomes a choice, not a default.
Clinical uncertainty will never be eliminated. Nor should it be, medicine is inherently complex, and variation in patient presentation is unavoidable. But the way systems respond to uncertainty can be redesigned.
At present, much of the NHS manages uncertainty by pushing it downstream. Referrals increase. Demand accumulates. Pressure builds. A more effective approach is to address uncertainty at the point where decisions are made.
That means investing in visibility, access to advice, and pathway clarity. It means recognising that many of the pressures facing secondary care are not just a function of demand, but of how that demand is generated. And it means accepting that improving flow is not simply about increasing capacity, but about improving confidence. Because when clarity improves, flow improves. And when flow improves, capacity follows.
See how you could save money with smarter digital pathways.
.svg)
